GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TC BioPharm (Holdings) PLC (OTCPK:TCBPY) » Definitions » Sale Of Property, Plant, Equipment

TCBPY (TC BioPharm (Holdings)) Sale Of Property, Plant, Equipment : $0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is TC BioPharm (Holdings) Sale Of Property, Plant, Equipment?

TC BioPharm (Holdings)'s sale of property, plant, equipment for the three months ended in Jun. 2024 was $0.00 Mil. It means TC BioPharm (Holdings) gained $0.00 Mil from selling property, plant, and equipment. TC BioPharm (Holdings)'s sale of property, plant, equipment for the trailing twelve months (TTM) ended in Jun. 2024 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Mar. 2024 ), TC BioPharm (Holdings) gained the same money from selling property, plant, and equipment in Jun. 2024 ($0.00 Mil).


TC BioPharm (Holdings) Sale Of Property, Plant, Equipment Historical Data

The historical data trend for TC BioPharm (Holdings)'s Sale Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TC BioPharm (Holdings) Sale Of Property, Plant, Equipment Chart

TC BioPharm (Holdings) Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Property, Plant, Equipment
- - - 0.07 -

TC BioPharm (Holdings) Quarterly Data
Dec19 Dec20 Sep21 Dec21 Jun22 Dec22 Mar23 Jun23 Dec23 Mar24 Jun24
Sale Of Property, Plant, Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

TC BioPharm (Holdings) Sale Of Property, Plant, Equipment Calculation

The amount earned to sell PPE.

Sale Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TC BioPharm (Holdings) Sale Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of TC BioPharm (Holdings)'s Sale Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.


TC BioPharm (Holdings) Business Description

Traded in Other Exchanges
N/A
Address
Maxim 1, 2 Parklands Way, Holytown, Motherwell, Scotland, GBR, ML1 4WR
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.
Executives
Renaissance Capital Partners Ltd 10 percent owner 42 SHAD THAMES, LONDON X0 SE1 2YD
Diana Elizabeth Randall 10 percent owner C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD
Kenneth Edward Randall 10 percent owner C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD
Mark Edward Randall 10 percent owner C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD